
Sarae L. Bausch
Examiner (ID: 12480, Phone: (571)272-2912 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1699 |
| Total Applications | 1041 |
| Issued Applications | 199 |
| Pending Applications | 206 |
| Abandoned Applications | 655 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17867520
[patent_doc_number] => 20220290256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/743790
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743790 | Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor | May 12, 2022 | Issued |
Array
(
[id] => 19684436
[patent_doc_number] => 20250002981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => REAGENTS AND DETECTION METHODS FOR FLUORESCENCE IN SITU HYBRIDIZATION
[patent_app_type] => utility
[patent_app_number] => 18/263456
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263456 | REAGENTS AND DETECTION METHODS FOR FLUORESCENCE IN SITU HYBRIDIZATION | Apr 28, 2022 | Pending |
Array
(
[id] => 19601499
[patent_doc_number] => 20240392379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => METHODS OF TREATING CANCERS HAVING A BIALLELIC LOSS OF FUNCTION OR GENE OVEREXPRESSION MUTATION
[patent_app_type] => utility
[patent_app_number] => 18/288308
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -103
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288308 | METHODS OF TREATING CANCERS HAVING A BIALLELIC LOSS OF FUNCTION OR GENE OVEREXPRESSION MUTATION | Apr 27, 2022 | Pending |
Array
(
[id] => 18021080
[patent_doc_number] => 20220372579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS FOR DETECTING CpG METHYLATION AND FOR DIAGNOSING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/730100
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730100 | Methods for detecting CpG methylation and for diagnosing cancer | Apr 25, 2022 | Issued |
Array
(
[id] => 18726329
[patent_doc_number] => 20230340604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHODS OF TREATMENT AND DIAGNOSIS OF MULTIPLE MYELOMA PROGRESSION
[patent_app_type] => utility
[patent_app_number] => 17/659946
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659946 | METHODS OF TREATMENT AND DIAGNOSIS OF MULTIPLE MYELOMA PROGRESSION | Apr 19, 2022 | Pending |
Array
(
[id] => 17750013
[patent_doc_number] => 20220228218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Clinical and Molecular Prognostic Markers for Liver Transplantation
[patent_app_type] => utility
[patent_app_number] => 17/712201
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712201 | Clinical and Molecular Prognostic Markers for Liver Transplantation | Apr 3, 2022 | Pending |
Array
(
[id] => 19572253
[patent_doc_number] => 20240376545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => FOLLICULAR THYROID CANCER-SPECIFIC MARKER
[patent_app_type] => utility
[patent_app_number] => 18/552985
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552985
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552985 | FOLLICULAR THYROID CANCER-SPECIFIC MARKER | Mar 28, 2022 | Pending |
Array
(
[id] => 18168090
[patent_doc_number] => 20230034700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => Methods of Administering 3,4-Diaminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/686895
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686895 | Methods of Administering 3,4-Diaminopyridine | Mar 3, 2022 | Abandoned |
Array
(
[id] => 17960390
[patent_doc_number] => 20220340970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/668697
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668697 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF | Feb 9, 2022 | Abandoned |
Array
(
[id] => 19098205
[patent_doc_number] => 20240117433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => PREPARATION METHOD FOR NUCLEIC ACID SAMPLE DERIVED FROM SKIN STRATUM CORNEUM
[patent_app_type] => utility
[patent_app_number] => 18/276844
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276844
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276844 | PREPARATION METHOD FOR NUCLEIC ACID SAMPLE DERIVED FROM SKIN STRATUM CORNEUM | Feb 9, 2022 | Pending |
Array
(
[id] => 20220221
[patent_doc_number] => 20250283152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => NUCLEIC ACID AMPLIFICATION USING PROMOTER PRIMERS
[patent_app_type] => utility
[patent_app_number] => 18/276110
[patent_app_country] => US
[patent_app_date] => 2022-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276110
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276110 | NUCLEIC ACID AMPLIFICATION USING PROMOTER PRIMERS | Feb 7, 2022 | Pending |
Array
(
[id] => 19021300
[patent_doc_number] => 20240077471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases
[patent_app_type] => utility
[patent_app_number] => 18/260220
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260220
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260220 | Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases | Jan 27, 2022 | Pending |
Array
(
[id] => 18996233
[patent_doc_number] => 11913066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => SE33 mutations impacting genotype concordance
[patent_app_type] => utility
[patent_app_number] => 17/585161
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 15797
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585161
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585161 | SE33 mutations impacting genotype concordance | Jan 25, 2022 | Issued |
Array
(
[id] => 17792566
[patent_doc_number] => 20220251657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => GENOMIC DIAGNOSTIC METHOD AND KIT TO DIAGNOSE EARLY ESOPHAGEAL CANCER AND BARRETTS ESOPHAGUS
[patent_app_type] => utility
[patent_app_number] => 17/582510
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582510 | GENOMIC DIAGNOSTIC METHOD AND KIT TO DIAGNOSE EARLY ESOPHAGEAL CANCER AND BARRETTS ESOPHAGUS | Jan 23, 2022 | Abandoned |
Array
(
[id] => 19319575
[patent_doc_number] => 20240241118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/289332
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289332 | AUTOANTIBODIES FOR USE IN IDENTIFYING DISEASE | Jan 23, 2022 | Pending |
Array
(
[id] => 20744250
[patent_doc_number] => 12644147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Method for multiplex nucleic acid detection based on clustered regularly interspaced short palindromic repeat
[patent_app_type] => utility
[patent_app_number] => 17/648180
[patent_app_country] => US
[patent_app_date] => 2022-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6191
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17648180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/648180 | Method for multiplex nucleic acid detection based on clustered regularly interspaced short palindromic repeat | Jan 17, 2022 | Issued |
Array
(
[id] => 17705041
[patent_doc_number] => 20220205047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHOD OF DIAGNOSING BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/571248
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571248
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/571248 | Method of diagnosing bladder cancer | Jan 6, 2022 | Issued |
Array
(
[id] => 17673157
[patent_doc_number] => 20220186324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MOLECULAR MARKERS RELATED TO MUTATION OF COARSE WOOL RATE AND WOOL FIBER DIAMETER OF LONG-HAIRED RABBIT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/545865
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545865
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545865 | MOLECULAR MARKERS RELATED TO MUTATION OF COARSE WOOL RATE AND WOOL FIBER DIAMETER OF LONG-HAIRED RABBIT AND USE THEREOF | Dec 7, 2021 | Abandoned |
Array
(
[id] => 19067678
[patent_doc_number] => 20240102104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 18/266404
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -173
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | Dec 7, 2021 | Pending |
Array
(
[id] => 17688205
[patent_doc_number] => 20220195497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => HYBRIDIZING all-LNA OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/544110
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544110 | HYBRIDIZING all-LNA OLIGONUCLEOTIDES | Dec 6, 2021 | Pending |